Leandro Venturutti
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology
Most-Cited Works
- → Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response(2020)151 cited
- → TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate(2020)114 cited
- → TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer(2016)108 cited
- → Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development(2012)105 cited
- → MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1(2016)82 cited
- → Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis(2015)65 cited
- → Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance(2014)56 cited
- → Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth(2014)44 cited
- → Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer(2017)38 cited
- → The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs(2020)36 cited